Offerings

Publications

Practice Leader
(800) 238-1230



A number of life science companies are at a crossroads with respect to their CRM solution. A number have on-premise sales force automation (SFA) solutions that are now coming due for upgrades, at the end of their depreciation schedule, or both. This dynamic is leading a number of our clients to re-evaluate the business functionality, flexibility, and technology investments they want to make.

HighPoint has assisted both large and specialty pharmaceutical companies assess their current situation, future direction, and a roadmap for how to get there. Through our experience, a number of those clients have evaluated SaaS technology alternatives.


Listed below are value propositions for SaaS solutions:

  • Reduced start-up cost, particularly valuable to small and mid tier pharma
  • Scalable and easy to configure solution
  • Faster time to implement (6 weeks to 3 months)
  • Reduction in support costs between SaaS SFA and onsite SFA solution, primarily from infrastructure

Our HighPoint sales & marketing consultants have over 60 years of experience in implementing and designing both traditional and SaaS SFA solutions. Our experience can help you evaluate whether SaaS SFA , in terms of total cost and functionality, is a good fit and option for your company.